Cladribine
- Generic Name
- Cladribine
- Brand Names
- Litak, Mavenclad
- Drug Type
- Small Molecule
- Chemical Formula
- C10H12ClN5O3
- CAS Number
- 4291-63-8
- Unique Ingredient Identifier
- 47M74X9YT5
Overview
An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia.
Background
An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia.
Indication
For the treatment of active hairy cell leukemia (leukemic reticuloendotheliosis) as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms. Also used as an alternative agent for the treatment of chronic lymphocytic leukemia (CLL), low-grade non-Hodgkin's lymphoma, and cutaneous T-cell lymphoma.
Associated Conditions
- Chronic Lymphocytic Leukemia
- Cutaneous T-Cell Lymphoma (CTCL)
- Hairy Cell Leukemia (HCL)
- Non-Hodgkin's Lymphomas
- Active confirmed by clinical features, confirmed by imaging features relapsing multiple sclerosis (MS)
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath